1.09k likes | 1.49k Views
Objectives. At the end of this segment, when given a clinical presentation, gross specimen, and/or photomicrograph, students will be able to:Compare and contrast the clinical presentations, etiologies, pathogenesis, and gross and microscopic changes found in developmental, inflammatory, circulatory
E N D
1. Pathology of the Large Intestine Aiman Zaher, MD
2. Objectives At the end of this segment, when given a clinical presentation, gross specimen, and/or photomicrograph, students will be able to:
Compare and contrast the clinical presentations, etiologies, pathogenesis, and gross and microscopic changes found in developmental, inflammatory, circulatory, mechanical, and neoplastic disorders of the large intestine.
3. Objectives At the end of this segment, when given a clinical presentation, gross specimen, and/or photomicrograph students will be able to:
Predict the clinical complications associated with diseases of the large intestine.
Define the words in the glossary
4. Glossary Diverticulum
Polyps
Pedunculated
Sessile
5. Structure and Function
6. Gross
~1.5 meters long
Cecum, ascending colon, transverse colon, descending colon, and sigmoid colon.
Sigmoid becomes rectum at the level of the third sacral vertebra.
Blood Supply
Ascending & proximal transverse colon – superior mesenteric artery
Remainder of colon to rectum – Inferior mesenteric artery
Upper rectum – Superior hemorrhoidal branch of inferior mesenteric artery
Lower rectum – hemorrhoidal branches of iliac or internal pudendal artery.
7. The purpose of the colon is to reclaim water and electrolytes.
Histology
Mucosa is flat without villi
Numerous straight tubular crypts extending to muscularis.
Surface cells are columnar with numerous goblet cells.
Crypts contain numerous goblet cells, endocrine cells and stem cells.
Paneth cells not as abundant as in small intestine
8. Congenital Anomalies
9. Congenital Aganglionic Megacolon:Hirschsprung Disease Absence of ganglion cells (in Auerbach’s and Meissner’s plexi) in a portion of the intestinal tract
Due to problems with neural crest cell migration or early death of ganglion cells
Leads to functional obstruction and massive intestinal dilatation proximal to the aganglionic segment
Most cases rectum and sigmoid only
Complications include enterocolitis and perforation of the colon or appendix with peritonitis
Manifests in newborns as failure to pass meconium and constipation
Acquired megacolon: results from Chagas disease, obstruction by neoplasm or inflammation, and as complications of inflammatory bowel disease
10. Hirschsprung Disease - Morphology
11. Inflammatory Disorders
12. Antibiotic Associated Colitis(Pseudomembranous) Definition
Acute colitis characterized by formation of an adherent inflammatory exudate overlying sites of mucosal injury = pseudomembrane
Etiology
Clostridium difficile
Normal part of gut flora
Toxins A and B cause host cell apoptosis
May occur without antibiotic therapy: after surgery or debilitating illnesses
Pathogenesis
Usually occurs in patients following a course of broad-spectrum antibiotics (almost all antibacterials implicated)
Toxin-producing strains flourish when normal flora disrupted
13. Antibiotic Associated Colitis(Pseudomembranous)
16. Antibiotic Associated Colitis(Pseudomembranous) Clinical Features
Adults: acute or chronic diarrheal illness
Diagnosis: C. difficile cytotoxin in stool
Relapse occurs in up to 25%
Treat with Vancomycin
17. Idiopathic Inflammatory Bowel Disease Collective term for Crohn disease and ulcerative colitis, because of their shared features
Results from inappropriate and persistent activation of the mucosal immune system
Distinct clinicopathologic manifestations:
Crohn disease: granulomatous (50%) and can be found from the esophagus to anus, most often intestine and colon; transmural
Ulcerative colitis: nongranulomatous, confined to colon and rectum, and superficial
Both have extraintestinal inflammatory processes associated
19. Etiology and Pathogenesis
Genetic Predisposition
15% of IBD patients have affected first-degree relatives; lifetime risk if either a parent or sibling is affected is 9%
HLA-DR1/DQw5 – 27% of North American white patients w/ CD
HLA-DR2 – patients w/ UC
HLA-B27 – pts with IBD & ankylosing spondylitis
Genetics suggest that CD and UC are distinct diseases.
Infectious causes
Host of organisms have been studied and none eluded; gene-knockout mice that normaly develop IBD do not develop it when they are germ free
Abnormal Host Immunoreactivity
Thought that there is too much T-cell activation and/or too little control by regulatory T lymphocytes
Inflammation is Final Common Pathway
20. Crohn Disease
22. Crohn Disease Any region of bowel; sm. intestine (40%), small & large intestine (30%), colon (30%)
Epidemiology
World-wide, but most prevelant in developed Western countries
Any age; peak incidence in 2nd & 3rd decades; and minor peak in 6th & 7th decades
F>M; whites 2-5X >non-whites
US: Jews 3-5X > non-Jews
Smoking is a strong risk factor
23.
25. Next SlideNext Slide
28. Crohn Disease Clinical Features
Intermittent attacks of diarrhea, fever, and abdominal pain separated by weeks to months that are asymptomatic
Attacks usually caused by periods of physical or emotional stress
May have occult blood loss, leading to anemia, but no massive bleeds
Some may have severe right lower quadrant pain
29. Crohn Disease Clinical Complications
Strictures
Fistulas
Malabsorption and protein-losing enteropathy
Extra-intestinal Manifestations
Migratory polyarthritis
Sacroilitis
Ankylosing spondylitis
Erythema nodosum
Primary sclerosing cholangitis
Clubbing of fingertips
5-6 fold increase in GI cancer, but less risk than in ulcerative colitis
30. Ulcerative Colitis Definition
Ulceroinflammatory disease of the colon, limited to mucosa & submucosa (except in severe cases)
No granulomas
Involves rectum and extends continuously proximally, leading to pancolitis
No skip lesions
Slightly more common than Crohn Disease and affects same type of patient
Associated with nonsmoking, particularly ex-smokers
38. Ulcerative Colitis Clinical Features
Relapsing bouts of bloody, mucoid diarrhea, persisting for days, weeks or months. Relapse after months, years or decades.
Usually accompanied by lower abdominal pain and cramps, relieved by defecation
Attacks usually associated with physical or emotional stress
97% have at least one relapse during a 10-year period
30% require colectomy in first three years of onset due to uncontrollable disease
Clinical Complications
Cancer
20-30X risk with pancolitis of 10> years
Associated carcinomas often infiltrative w/out obvious masses
Actual rate of progression to dysplasia & CA is low
Toxic Megacolon
Extraintestinal lesions
40. Circulatory Disorders
41. Angiodysplasia Definition
Tortuous dilations of submucosal and mucosal blood vessels in cecum or right colon
Epidemiology
< 1% of adult population, but 20% of significant lower GI bleeds (including chronic and intermittent or acute and massive bleeding)
Usually after age 60
Etiology and Pathogenesis
Normal distention and contraction of wall may occlude the submucosal veins ? focal dilatation
LaPlace’s Law states that tension in the wall of cylinder is a function of intraluminal P & diameter; cecum has widest diameter and therefore greatest tension
Vascular degenerative changes
43. Angiodysplasia Clinical Features
Manifested as variable bleeding; some massive and severe.
Hematochezia
44. Hemorrhoids Definition
Variceal dilations of the anal and perianal venous plexuses.
Microscopically, are thin-walled, dilated, submucosal vessels
Types
Internal: superior plexus; above anorectal line
External: inferior plexus; below anorectal line
Etiology and Pathogenesis
5% of general population
Rarely under 30 years of age, unless pregnant
Secondary to persistently elevated venous pressure within the plexi
Chronic constipation and straining
Pregnancy (venous stasis)
Liver Cirrhosis & Portal Hypertension
46. Hemorrhoids Clinical Features
Hemorrhage
When traumatized ? thrombosis ? recanalization.
Ulceration, fissures and infarction due to strangulation
47. Obstructions/ Dilatations
48. Diverticular Disease Definition
A blind pouch lined by mucosa that communicates with lumen of gut
Congenital - all three layers of bowel wall e.g Meckel diverticulum
Acquired - lack or have attenuated muscularis propria
49. Diverticular Disease Epidemiology
Rare < 30; In Western countries 50% incidence in age 60+
Can occur throughout the GI tract, but most commonly in the left colon (particularly sigmoid)
Usually multiple present and the condition called, “diverticulosis”
Etiology and Pathogenesis
Focal wall weakness + ? intralumenal pressure
Longitudinal muscle coat incomplete (taenia coli) in colon ? leaving regions where nerves and arterial vasa recta penetrate; connective tissue sheaths around vessels are areas for herniation
? Peristalsis ? sequester bowel segments ? ? intralumenal pressure ? ? inflammation
Possibly diets low in fiber reduce stool bulk, ? peristalsis
50. 2. Microscopic - 1 slide
a. thin wall with flattened or atrophic mucosa, compressed submucosa and attenuated or missing muscularis2. Microscopic - 1 slide
a. thin wall with flattened or atrophic mucosa, compressed submucosa and attenuated or missing muscularis
53. Diverticular Disease Clinical Features
Most asymptomatic
20% symptomatic
Intermittent cramping, lower abdominal discomfort, constipation, distention, feeling like rectum won’t completely empty, alternating constipation & diarrhea, minimal chronic or intermittent blood loss or rarely massive hemorrhage
Clinical Complications
Obstruction ? Inflammation ? Perforation ? Pericolic abscesses ? fibrosis and/or sinus tracts ? peritonitis
55. Tumors of the Colon and Rectum
56. What is a Polyp? A tumorous mass that protrudes into the gut lumen
Presumably, all polpys start as small, sessile lesions without a stalk and then devlop into stalked, pedunculated polyps.
57. How are polyps formed? Non-neoplastic (hyperplastic polyps)
Abnormal mucosal maturation
Inflammation
Architecture
Neoplastic
Proliferation and Dysplasia (adenomatous polyps, adenomas)
These are precursors to carcinoma!
Submucosal or mural tumors give rise to polypoid lesions
*Unless otherwise specified, polyps are epithelial and arise from mucosa.
58. Benign Lesions
59. Non-Neoplastic Polyps
60. Hyperplastic Polyps Patients 60+
Nipple-like protrusions into lumen; often multiple
Histology - well-formed glands and crypts lined by non-neoplastic cells
Virtually no malignant potential
61. Hyperplastic Polyps - Morphology
62. Juvenile Polyps Focal hamartomatous malformations in mucosa and lamina propria
Sporadic and majority in children < 5 yrs
Large (1-3 cm), round, smooth and lobulated with up to 2 cm stalks
No malignant potential except for a rare autosomal dominant juvenile polyposis syndrome
50-100 juvenile polyps in GI tract
63. Juvenile Polyps - Morphology
64. Juvenile Polyps - Morphology
65. Peutz-Jeghers Polyps Hamartomatous polpys of mucosa, lamina propria, and muscularis mucosa
Either single or
Multiple throughout GI tract, as in P-J Syndrome
melanotic mucosal and cutaneous pigmentation around oral mucosa, lips, face, genitalia, and palmer surface of hands
risk of intussusception, causing death
The polyps have no malignant potential, but patients with syndrome have increased risk of carcinoma of pancreas, breast, lung, ovary and uterus
66. Adenomas Epidemiology
Small pedunculated to large neoplasms that are sessile
Prevalence is 20-30% < 40 yrs to 40-50% > 60 yrs
Familial predisposition for sporadic adenomas (4X risk for 1st degree relatives and 4X risk for colorectal cancer)
67. Adenomas Classification
Tubular adenomas
Most common
>75% tubular architecture, small & pedunculated
Villous adenomas:
Least common
>50% villous architecture
Tubulovillous adenoma
Mixture of the other two
25-50% villous architecture
68. Adenomas Malignant Risk
Adenomas arise from proliferative dysplasia that varies in severity; they are precursors to invasive colorectal adenocarcinoma
Polyp size, histologic architecture, & severity of dysplasia determines risk of malignancy
Rare in tubular adenomas <1 cm
Up to 40% of villous adenomas > 4cm
Usually contains severe dysplasia
77. Adenomas Clinical Features
Regardless of whether carcinoma is present, the only adequate treatment for a pedunculated or sessile adenoma is complete resection.
If adenomatous tissue is left behind, the patient still has a premalignant lesion.
78. Familial Syndromes Onset in teens to twenties in all syndromes and cancer 10-15 years later
Autosomal dominant diseases
Familial adenomatous polyposis (FAP)
Archetype familial adenomatous polyposis syndrome
Caused by mutations of the adenomatous polyposis coli (APC) gene on chromosome 5
Exhibits innumerable adenomatous polyps that carpet the mucosa
100% frequency of progression to adenocarcinoma
Gardner syndrome
Variation of FAP
Addition of osteomas (mandible, skull & lung bones), epidermal cysts, and fibromatosis
Turcot syndrome
Rare
Adenomatous colonic polyposis + CNS tumors (gliomas)
80. Malignant Lesions
81. Adenocarcinoma
Epidemiology
Adenocarcinomas (98% of cancer in colon)
10% of all cancer related deaths in US
Peak incident 60-79 years
Highest death rates in US and Eastern European countries
-high refined CHO ? toxic oxidative products held in slow moving small bulk stools against mucosa
- red meat e.g. ?cholesterol? synth bile acids ?bact ? carcinogens?
-decreased protective micronutrients e.g. Vit A,C,E -high refined CHO ? toxic oxidative products held in slow moving small bulk stools against mucosa
- red meat e.g. ?cholesterol? synth bile acids ?bact ? carcinogens?
-decreased protective micronutrients e.g. Vit A,C,E
82. Adenocarcinoma Etiology and Pathogenesis
Must suspect preexisting UC or Polyposis Syndrome if found in young person
Diet implicated
Excess caloric intake relative to requirements
Low unabsorbable vegetable fiber ? reduces transit time & yields scanty stool
Large quantities of refined carbohydrates ? toxic oxidative products held in contact with mucosa by slow-moving stools
Red meat
High cholesterol ? synthesizes bile acids ? converted into carcinogens by bacteria
Decreased intake of protective micronutrients, e.g. Vit A,C,E
86. Adenocarcinoma Clinical Features
Asymptomatic for years and then insidious onset
Right sided
Fatigue, weakness, iron deficiency anemia
Lesions are bulky and bleed easily
Left sided
Occult blood in stool
Alternating constipation and diarrhea
Crampy discomfort in left lower quadrant
Rectum & sigmoid more infiltrative at time of diagnosis ? poorer prognosis
Iron deficiency anemia in an older man is GI cancer until proven otherwise.
87. Adenocarcinoma Complications
Weight loss, malaise, & weakness are ominous signs
Metastasis by lymph and blood
In order of metastatic spread: regional nodes, liver, lungs and bone
Extent of tumor at time of diagnosis (stage) is the most important prognostic indicator.
89. Carcinoid Tumors Source
Endocrine cells throughout GI tract can generate bioactive compounds that coordinate gut function (gastrin, vasoactive amines, somatostatin & insulin)
Epithelial cells that functionally and morphologically resemble endocrine cells
Epidemiology
Most located in GI tract
Peak incidence in 50s
< 2% of colorectal malignancies, 50% of small intestinal malignancies
Site is important in terms of biologic behavior because there is no reliable histological difference between benign & malignant carcinoids
93. Carcinoid Tumors Clinical Features
Many asymptomatic
May obstruct
May be functional e.g. hyperinsulinemia, Cushing Syndrome, Zollinger-Ellison Syndrome
May have Carcinoid Syndrome
1% of all patients; 20% with widespread metastases
Excess elaboration of serotonin; 5-HT and its metabolite (5-HIAA) are present in the blood and urine of patients
Symptoms: flushing, intestinal hypermotility, bronchoconstriction, hepatomegaly, and systemic fibrosis
94. Carcinoid Tumors Clinical Complications
Liver metastasis
5 year survival 90% (excluding appendiceal)
50% if small bowel tumor with liver metastasis
Wide spread disease will usually cause death
95. Gastrointestinal Lymphoma Definition
Primary GI lymphomas exhibit no evidence of liver, spleen, mediastinal lymph node, or bone marrow involvement at the time of diagnosis
Regional lymph node involvement may be present
Who gets them?
Sporadic, H. pylori gastritis, Mediterranean population, congenital immunodeficiency, HIV, Celiac sprue, immunosuppressive therapy
96. Gastrointestinal Lymphoma Clinical Features
Tumors start as plaques then become exophytic or infiltrative
Symptoms vague to prominent: weakness and weight loss
Ulcerate leading to bleeding
Tumors invade and perforate
Obstruction
Complications
Depth of invasion, size of tumor, histologic grade and extension determine prognosis
85% 10-year survival if localized to mucosa or submucosa
97. Appendix
98. Acute Appendicitis Epidemiology
Mainly adolescents and young adults
Males slight more often than females
Etiology and Pathogenesis
Obstruction by fecoliths (most common), gallstones, tumors or parasites
Obstruction ? mucous secretion ? ? intralumenal pressure ? collapse of draining veins ? ischemia ? bacterial proliferation ? further inflammation with edema ? ?blood flow
Some have an unknown cause
101. Acute Appendicitis Clinical Features
Classic signs are periumbilical pain to lower right quadrant, nausea and/or vomiting, abdominal tenderness in the region of the appendix, mild fever and leukocytosis (15-20 thousand)
Classic signs absent more than present, especially in young children and elderly
Surgical false positives 20-25% of the time, but significant mortality rate (2% w/ perforation) outweighs this fact.
Clinical Complications
Perforation leading to
periumbilical abscess
local peritonitis
102. Peritonitis
103. Peritonitis Common Causes
Sterile peritonitis from leakage of bile or pancreatic enzymes
Perforation or rupture of biliary system
Acute hemorrhagic pancreatitis
Surgical procedures
Gynecologic conditions (endometriosis & ruptured dermoid cysts)
104. Neoplasms Mesotheliomas
Extremely rare
Same as those found in pleural cavity and pericardium
Associated with asbestos exposure in 80%
Secondary tumors (Metastatic)
Common
Diffuse serosal implantation e.g ovarian and pancreatic tumors
Mucinous cystadenocarcinomas of appendix implant peritoneum ? mucin = pseudomyxoma peritoneii
105. References Kumar, Abbas, and Fausto: ROBBINS AND COTRAN PATHOLOGIC BASIS OF DISEASE, 7th Edition, pp.828-870.